State Street Corp Atossa Therapeutics, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 516,571 shares of ATOS stock, worth $397,759. This represents 0.0% of its overall portfolio holdings.
Number of Shares
516,571
Previous 1,727,090
70.09%
Holding current value
$397,759
Previous $1.16 Million
63.01%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ATOS
# of Institutions
87Shares Held
28.6MCall Options Held
12.7KPut Options Held
92.9K-
Black Rock Inc. New York, NY9.2MShares$7.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$4.49 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.97MShares$2.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.58 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.81MShares$1.4 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $97.5M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...